Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sorafenib Treatment Modalities for HEpatoceLLular Carcinoma Patients in ItAly

NCT01539681 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01539681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01539681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sorafenib Treatment Modalities for HEpatoceLLular Carcinoma Patients in ItAly
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
February 28, 2015
Enrollment
234 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma